Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polyunsaturated fatty acids (PUFAs) are essential structural components of cellular and mitochondrial membranes, where they maintain fluidity and serve as precursors for signaling molecules [1]. However, the presence of bis-allylic hydrogen atoms makes PUFAs highly susceptible to attack by reactive oxygen species, leading to the formation of lipid peroxyl radicals (LOO•) [1, 2]. These radicals initiate a self-propagating chain reaction of lipid peroxidation that severely damages membrane integrity and can trigger ferroptosis, a form of iron-dependent regulated cell death [2, 4]. This oxidative degradation is a hallmark of various pathological states, including neurodegenerative diseases like Parkinson's and Alzheimer's, as well as ischemia-reperfusion injury and certain cancers [1, 2]. Therapeutic strategies targeting these molecules include radical-trapping antioxidants (RTAs) such as Ferrostatin-1 and Liproxstatin-1, which scavenge peroxyl radicals to terminate the peroxidation chain [4]. Additionally, the use of deuterated PUFAs (e.g., RT-001) provides a novel approach by using the kinetic isotope effect to stabilize the bis-allylic positions against hydrogen abstraction, thereby preventing the initiation of the radical cascade [3]. By protecting the lipid bilayer from oxidative degradation, these interventions aim to preserve cellular viability and mitochondrial function under conditions of high oxidative stress [2, 4].
Radical trapping and neutralization of lipid peroxyl radicals to terminate peroxidation chains, and isotopic stabilization of bis-allylic positions to inhibit hydrogen abstraction.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid bilayer polyunsaturated fatty acids and lipid peroxyl radicals in cellular and mitochondrial membranes (PUFA/LOO•).